A new trading day began on Friday, with Theriva Biologics Inc (AMEX: TOVX) stock price up 6.44% from the previous day of trading, before settling in for the closing price of $0.44. TOVX’s price has ranged from $0.37 to $7.15 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 39.99% over the last five years. Meanwhile, its annual earnings per share averaged 88.70%. With a float of $9.50 million, this company’s outstanding shares have now reached $9.60 million.
The firm has a total of 22 workers. Let’s measure their productivity. In terms of profitability, gross margin is -5.84%, operating margin of -13547.4%, and the pretax margin is -19190.91%.
Theriva Biologics Inc (TOVX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Theriva Biologics Inc is 1.04%, while institutional ownership is 7.94%.
Theriva Biologics Inc (TOVX) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -6.81 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 88.70% per share during the next fiscal year.
Theriva Biologics Inc (AMEX: TOVX) Trading Performance Indicators
Here are Theriva Biologics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.90, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -0.75 in one year’s time.
Technical Analysis of Theriva Biologics Inc (TOVX)
Analysing the last 5-days average volume posted by the [Theriva Biologics Inc, TOVX], we can find that recorded value of 2.65 million was better than the volume posted last year of 0.76 million. As of the previous 9 days, the stock’s Stochastic %D was 67.23%.
During the past 100 days, Theriva Biologics Inc’s (TOVX) raw stochastic average was set at 8.60%, which indicates a significant decrease from 55.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0450 in the past 14 days, which was lower than the 0.0682 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4555, while its 200-day Moving Average is $1.0708. Now, the first resistance to watch is $0.5302. This is followed by the second major resistance level at $0.5974. The third major resistance level sits at $0.6525. If the price goes on to break the first support level at $0.4079, it is likely to go to the next support level at $0.3528. Now, if the price goes above the second support level, the third support stands at $0.2856.
Theriva Biologics Inc (AMEX: TOVX) Key Stats
With a market capitalization of 4.44 million, the company has a total of 9,598K Shares Outstanding. Currently, annual sales are 0 K while annual income is -25,650 K. The company’s previous quarter sales were 0 K while its latest quarter income was -4,320 K.
